1Artaud-Wild, SM, Connor, SL, Sexton, G, et al. (1993) Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88, 2771–2779.
2Wood, R, Kubena, K, O'Brien, B, et al. (1993) Effect of butter, mono- and polyunsaturated fatty acid-enriched butter, trans fatty acid margarine, and zero trans fatty acid margarine on serum lipids and lipoproteins in healthy men. J Lipid Res 34, 1–11.
3Noakes, M, Nestel, PJ & Clifton, PM (1996) Modifying the fatty acid profile of dairy products through feedlot technology lowers plasma cholesterol of humans consuming the products. Am J Clin Nutr 63, 42–46.
4Menotti, A, Kromhout, D, Blackburn, H, et al. (1999) Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur J Epidemiol 15, 507–515.
5Mozaffarian, D, Micha, R & Wallace, S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
6Jakobsen, MU, O'Reilly, EJ, Heitmann, BL, et al. (2009) Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 89, 1425–1432.
7Hooper, L, Summerbell, CD, Thompson, R, et al. (2011) Reduced or modified dietary fat for preventing cardiovascular disease. The Cochrane Database Systematic Reviews, CD002137.
8Siri-Tarino, PW, Sun, Q, Hu, FB, et al. (2010) Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 91, 535–546.
9Ambring, A, Johansson, M, Axelsen, M, et al. (2006) Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr 83, 575–581.
10Ferrucci, L, Cherubini, A, Bandinelli, S, et al. (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91, 439–446.
11Calder, PC (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
12Di Marzo, V (2008) The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 51, 1356–1367.
13Chilliard, Y, Ferlay, A, Mansbridge, RM, et al. (2000) Ruminant milk fat plasticity: nutritional control of saturated, polyunsaturated, trans and conjugated fatty acids. Ann Zootech 49, 181–205.
14Chilliard, Y, Glasser, F, Ferlay, A, et al. (2007) Diet, rumen biohydrogenation and nutritional quality of cow and goat milk fat. Eur J Lipid Sci Technol 109, 828–855.
15Mele, M (2009) Designing milk fat to improve healthfulness and functional properties of dairy products: from feeding strategies to a genetic approach. It J Anim Sci 8, 365–373.
16McLeod, RS, Le Blanc, AM, Langille, MA, et al. (2004) Conjugated linoleic acids, atherosclerosis, and hepatic very-low-density lipoprotein metabolism. Am J Clin Nutr 79, 1169S–1174S.
17Chardigny, JM, Destaillats, F, Malpuech-Brugere, C, et al. (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87, 558–566.
18Field, CJ, Blewett, HH, Proctor, S, et al. (2009) Human health benefits of vaccenic acid. Appl Physiol Nutr Metab 34, 979–991.
19Mele, M, Contarini, G, Cercaci, L, et al. (2011) Enrichment of pecorino cheese with conjugated linoleic acid by feeding dairy ewes with extruded linseed: effect on fatty acid and triglycerides composition and on oxidative stability. Int Dairy J 21, 365–372.
20German, JB, Gibson, RA, Krauss, RM, et al. (2009) A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr 48, 191–203.
21Aslibekyan, S, Campos, H & Baylin, A (2011) Biomarkers of dairy intake and the risk of heart disease. Nutr Metab Cardiovasc Dis (epublication ahead of print version 4 May 2011).
22Goldbohm, RA, Chorus, AM, Galindo Garre, F, et al. (2011) Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr 93, 615–627.
23Ivey, KL, Lewis, JR, Hodgson, JM, et al. (2011) Association between yogurt, milk, and cheese consumption and common carotid artery intima–media thickness and cardiovascular disease risk factors in elderly women. Am J Clin Nutr 94, 234–239.
24Elwood, PC, Pickering, JE & Fehily, AM (2007) Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health 61, 695–698.
25Warensjo, E, Jansson, JH, Cederholm, T, et al. (2010) Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case–control study. Am J Clin Nutr 92, 194–202.
26Stancliffe, RA, Thorpe, T & Zemel, MB (2011) Dairy attenuates oxidative and inflammatory stress in metabolic syndrome. Am J Clin Nutr 94, 422–430.
27Ritzenthaler, KL, McGuire, MK, McGuire, MA, et al. (2005) Consumption of conjugated linoleic acid (CLA) from CLA-enriched cheese does not alter milk fat or immunity in lactating women. J Nutr 135, 422–430.
28Tricon, S, Burdge, GC, Jones, EL, et al. (2006) Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr 83, 744–753.
29Sofi, F, Buccioni, A, Cesari, F, et al. (2010) Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutr Metab Cardiovasc Dis 20, 117–124.
30Kesaniemi, YA, Ehnholm, C & Miettinen, TA (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80, 578–581.
31Manttari, M, Koskinen, P, Ehnholm, C, et al. (1991) Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40, 217–221.
32Murakami, K, Shimizu, M, Yamada, N, et al. (1993) Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM. Diabetes Care 16, 564–569.
33Olivieri, O, Stranieri, C, Bassi, A, et al. (2002) ApoC-III gene polymorphisms and risk of coronary artery disease. J Lipid Res 43, 1450–1457.
34Turpeinen, AM, Mutanen, M, Aro, A, et al. (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76, 504–510.
35Kuhnt, K, Kraft, J, Moeckel, P, et al. (2006) trans-11-18 : 1 is effectively Delta9-desaturated compared with trans-12-18 : 1 in humans. Br J Nutr 95, 752–761.
36Folch, J, Lees, M & Sloane Stanley, GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497–509.
37Banni, S, Carta, G, Contini, MS, et al. (1996) Characterization of conjugated diene fatty acids in milk, dairy products, and lamb tissues. J Nutr Biochem 7, 150–155.
38Melis, MP, Angioni, E, Carta, G, et al. (2001) Characterization of conjugated linoleic acid and its metabolites by RP-HPLC with diode array detector. Eur J Lipid Sci Technol 103, 617–621.
39Angioni, E, Lercker, G, Frega, NG, et al. (2002) UV spectral properties of lipids as a tool for their identification. Eur J Lipid Sci Technol 104, 59–64.
40Cappa, M, Bizzarri, C, Petroni, A, et al. (2011) A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers. J Inher Metab Dis (epublication ahead of print version, 22 December 2011).
41Ip, C, Banni, S, Angioni, E, et al. (1999) Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 129, 2135–2142.
42Piscitelli, F, Carta, G, Bisogno, T, et al. (2011) Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab (Lond) 8, 51.
43Stark, KD (2008) The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 43, 45–53.
44Mantovani, G, Maccio, A, Esu, S, et al. (1994) Lack of correlation between defective cell-mediated-immunity and levels of secreted or circulating cytokines in a study of 90 cancer-patients. Int J Oncol 5, 1211–1217.
45Smedman, AEM, Gustafsson, IB, Berglund, LGT, et al. (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69, 22–29.
46Batetta, B, Griinari, M, Carta, G, et al. (2009) Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 139, 1495–1501.
47Banni, S, Carta, G, Murru, E, et al. (2011) Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab (Lond) 8, 7.
48Jumpertz, R, Guijarro, A, Pratley, RE, et al. (2011) Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. J Clin Endocrinol Metab 96, 787–791.
49Di Marzo, V & Despres, JP (2009) CB1 antagonists for obesity – what lessons have we learned from rimonabant? Nat Rev Endocrinol 5, 633–638.
50Tsuyama, S, Oikawa, D, Tsuji, Y, et al. (2009) Dietary conjugated linoleic acid modifies the brain endocannabinoid system in mice. Nutr Neurosci 12, 155–159.
51Wendland, E, Farmer, A, Glasziou, P, et al. (2006) Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92, 166–169.
52Pfeuffer, M, Fielitz, K, Laue, C, et al. (2011) CLA does not impair endothelial function and decreases body weight as compared with safflower oil in overweight and obese male subjects. J Am Coll Nutr 30, 19–28.
53Deedwania, P (2009) The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism. Int J Cardiol 131, 305–312.
54Jacome-Sosa, MM, Lu, J, Wang, Y, et al. (2010) Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat. Nutr Metab (Lond) 7, 60.
55Mensink, RP, Zock, PL, Kester, AD, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.
56Hjartaker, A, Lagiou, A, Slimani, N, et al. (2002) Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: data from 35 955 24-hour dietary recalls in 10 European countries. Public Health Nutr 5, 1259–1271.
57Meydani, M (1992) Vitamin E requirement in relation to dietary fish oil and oxidative stress in elderly. EXS 62, 411–418.
58Jenkinson, A, Franklin, MF, Wahle, K, et al. (1999) Dietary intakes of polyunsaturated fatty acids and indices of oxidative stress in human volunteers. Eur J Clin Nutr 53, 523–528.
59Riserus, U, Vessby, B, Arnlov, J, et al. (2004) Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80, 279–283.
60Iannone, A, Petroni, A, Murru, E, et al. (2009) Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA). Prostaglandins Leukot Essent Fatty Acids 80, 279–287.